Bullish Moving Averages
8
Bearish Moving Averages
8
Back Stocks profile
Stock analysis tool for investors
Performance
Today’s low
52.00Today’s High
53.0052W low
44.5052W High
86.10Open Price
53.00Prev. Close
52.5400Volume
6239.00Value
327609.89Fundamentals
Market Cap
68.60
Price to Earnings
-6.80
Price to Book Value
0.90
Dividend Yield
0.00
PE to Growth
0.00
Op Revenue TTM
146.11
Net Profit TTM
-10.14
Cash From Operating Activity
-9.49
Return on Equity %
-13.29
EMA & SMA
DELIVERY AND VOLUME
DAILY AVG. DELIVERY VOLUME %
05 Jul, 2024
53.6
Week
54.8
Month
67.6
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
52.50
PIVOT
First Resistance
53.01
Second Resistance
53.50
Third Resistance
54.01
First Support
52.01
Second Support
51.50
Third Support
51.01
Relative Strength Index
48.68
Money Flow Index
31.85
MACD
-0.37
MACD Signal
-0.52
Average True Range
2.11
Average Directional Index
20.35
Rate of Change (21)
1
Rate of Change (125)
-34.61
Commodity Channel Index
-2.9
Williams %R
-44.5
BETA
1 Month
-0.33
3 Month
0.07
1 Year
-0.02
3 Year
0.21
PRICE CHANGE ANALYSIS
↑ 1.7%
1 Week
Low
High
51.3
53.95
↓ -0.06%
1 Month
Low
High
50.65
55
↓ -8.68%
3 Months
Low
High
50
63.17
↓ -29.32%
6 Months
Low
High
44.49
77.31
↓ -21.64%
1 Year
Low
High
44.49
86.06
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 34.33 | 17.01 | 29.91 | 50.95 | 41.08 | 45.49 | 58.60 | 71.68 | 96.49 | 47.25 | 87.80 | |
| Operating Expenses Qtr | 30.24 | 18.82 | 28.26 | 44.94 | 43.48 | 43.03 | 44.15 | 60.28 | 83.75 | 42.41 | 68.55 | |
| Operating Profit Qtr | 3.84 | -1.71 | 1.32 | 5.67 | -11.59 | 2.14 | 14.24 | 11.28 | 12.12 | 4.70 | 19.13 | |
| EBIDT Qtr Cr | 2.35 | -1.80 | 1.65 | 6.01 | -2.40 | 2.46 | 14.44 | 11.40 | 12.74 | 4.84 | 19.25 | |
| Depreciation Qtr | 1.83 | 2.02 | 1.97 | 1.94 | 2.82 | 1.92 | 1.90 | 1.88 | 2.37 | 1.35 | 1.03 | |
| Net Profit Qtr | -3.60 | -4.59 | -2.05 | 1.60 | -5.03 | -1.60 | 7.62 | 3.34 | 5.28 | 1.22 | 12.66 | |
| Basic EPS Qtr | -2.73 | -3.51 | -1.53 | 1.28 | -3.96 | -1.22 | 2.19 | 3.84 | 5.19 | 1.24 | 12.24 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 132.20 | 216.85 | 349.62 | 154.93 | 127.25 | |
| Operating Expenses Annual Cr | 122.25 | 195.94 | 283.59 | 140.51 | 114.75 | |
| Operating Profit Annual | 9.12 | 11.07 | 65.08 | 13.87 | 12.08 | |
| Operating Profit Margin Annual % | 6.89 | 5.10 | 18.62 | 8.95 | 9.50 | |
| Total Expenses Annual Cr | 139.34 | 214.78 | 296.56 | 144.80 | 118.84 | |
| EBIDT Annual Cr | 9.95 | 20.91 | 66.03 | 14.42 | 12.50 | |
| EBIDT Annual margin % | 7.53 | 9.64 | 18.89 | 9.31 | 9.82 | |
| Depreciation | 7.75 | 8.52 | 5.12 | 1.32 | 1.23 | |
| PAT Before ExtraOrdinary Items Annual Cr | -8.65 | -0.66 | 39.71 | 7.03 | 6.10 | |
| Net Profit Annual | -8.65 | -0.66 | 39.71 | 7.03 | 6.10 | |
| Basic EPS Annual | -6.48 | 0.04 | 38.51 | 13.56 | 11.76 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 77.07 | 85.54 | 83.48 | 41.58 | 34.56 | |
| Minority Interest Liability Annual Cr | - | - | - | - | - | |
| Total Non Current Liabilities Annual Cr | 14.46 | 20.62 | 31.28 | 10.51 | 8.62 | |
| Total Current Liabilities Annual Cr | 125.90 | 146.36 | 153.92 | 91.56 | 50.90 | |
| Total Capital Plus Liabilities Annual Cr | 217.43 | 252.51 | 268.68 | 143.65 | 94.08 | |
| Fixed Assets Annual | 53.35 | 78.68 | 82.32 | 24.10 | 21.17 | |
| Total Non Current Assets Annual | 57.35 | 82.60 | 87.12 | 27.78 | 21.36 | |
| Total Current Assets Annual | 160.07 | 169.91 | 181.57 | 115.87 | 72.71 | |
| Total Assets Annual | 217.43 | 252.51 | 268.68 | 143.65 | 94.08 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 16.63 | 20.30 | 15.87 | 9.32 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | -13.13 | 26.01 | 27.39 | 9.14 | 4.83 | |
| Cash from Investing Activity Annual | 20.02 | -9.35 | -42.50 | -7.70 | -1.66 | |
| Cash from Financing Annual Activity | -7.00 | -16.75 | 15.29 | -1.19 | -3.95 | |
| Net Cash Flow Annual | - | -0.08 | 0.17 | 0.26 | -0.77 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 59.02 | 65.50 | 80.53 | 80.22 | 66.67 | |
| ROE Annual % | -11.22 | -0.77 | 47.57 | 16.90 | 17.64 | |
| ROCE Annual % | 2.39 | 11.67 | 53.07 | 25.15 | 26.10 | |
| Total Debt to Total Equity Annual | 0.72 | 0.62 | 0.73 | 0.96 | 0.53 | |
| EBDIT Annual Margin % | 7.57 | 10.10 | 18.93 | 9.34 | 9.85 |
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 38.03 | 18.52 | 33.49 | 56.78 | 48.67 | 47.16 | 59.98 | 73.80 | 95.95 | 49.77 | 89.56 | |
| Operating Expenses Qtr | 34.48 | 20.46 | 31.60 | 49.92 | 49.72 | 44.17 | 50.17 | 61.69 | 82.64 | 44.29 | 69.62 | |
| Operating Profit Qtr | 3.36 | -1.91 | 1.66 | 6.55 | -10.28 | 2.76 | 9.65 | 12.01 | 12.73 | 5.32 | 19.85 | |
| EBIDT Qtr Cr | 1.81 | -1.94 | 1.88 | 6.86 | -1.05 | 2.99 | 9.81 | 12.10 | 13.30 | 5.48 | 19.95 | |
| Depreciation Qtr | 2.05 | 1.91 | 2.22 | 2.19 | 3.03 | 2.13 | 2.11 | 2.09 | 2.61 | 1.53 | 1.20 | |
| Net Profit Qtr | -3.65 | -5.93 | -2.32 | 1.75 | -4.61 | -1.78 | 2.63 | 3.49 | 5.25 | 1.27 | 12.84 | |
| Basic EPS Qtr | -2.75 | -4.53 | -1.74 | 1.41 | -3.63 | -1.36 | 2.20 | 3.99 | 5.16 | 1.29 | 12.41 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Graph |
|---|---|---|---|---|
| Total Revenue Annual | 146.81 | 229.61 | 355.20 | |
| Operating Expenses Annual Cr | 136.46 | 205.76 | 286.92 | |
| Operating Profit Annual | 9.65 | 14.13 | 67.38 | |
| Operating Profit Margin Annual % | 6.57 | 6.16 | 18.97 | |
| Total Expenses Annual Cr | 155.79 | 226.99 | 301.70 | |
| EBIDT Annual Cr | 10.35 | 23.86 | 68.28 | |
| EBIDT Annual margin % | 7.05 | 10.39 | 19.22 | |
| Depreciation | 8.37 | 9.35 | 5.88 | |
| PAT Before ExtraOrdinary Items Annual Cr | -10.14 | -0.26 | 40.32 | |
| Net Profit Annual | -10.14 | -0.26 | 40.32 | |
| Basic EPS Annual | -7.61 | 0.36 | 39.39 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Graph |
|---|---|---|---|---|
| Total ShareHolders Funds Annual | 76.28 | 86.22 | 83.77 | |
| Minority Interest Liability Annual Cr | 0.00 | 0.00 | 0.00 | |
| Total Non Current Liabilities Annual Cr | 21.59 | 31.20 | 40.97 | |
| Total Current Liabilities Annual Cr | 144.57 | 162.28 | 166.29 | |
| Total Capital Plus Liabilities Annual Cr | 242.44 | 279.70 | 291.03 | |
| Fixed Assets Annual | 58.40 | 88.15 | 92.61 | |
| Total Non Current Assets Annual | 63.50 | 92.81 | 98.22 | |
| Total Current Assets Annual | 178.94 | 186.89 | 192.81 | |
| Total Assets Annual | 242.44 | 279.70 | 291.03 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 16.63 | 20.30 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Graph |
|---|---|---|---|---|
| Cash from Operating Activity Annual | -9.49 | 26.38 | 24.72 | |
| Cash from Investing Activity Annual | 19.89 | -9.32 | -44.41 | |
| Cash from Financing Annual Activity | -10.40 | -17.07 | 19.93 | |
| Net Cash Flow Annual | - | -0.02 | 0.23 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Graph |
|---|---|---|---|---|
| Book Value Per Share Annual | 58.41 | 66.02 | 80.81 | |
| ROE Annual % | -13.29 | -0.30 | 48.12 | |
| ROCE Annual % | 2.02 | 12.35 | 50.02 | |
| Total Debt to Total Equity Annual | 0.91 | 0.81 | 0.92 | |
| EBDIT Annual Margin % | 7.08 | 10.84 | 19.27 |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| RAJESH GUPTA | 70.41 | 75055300 | 45 | 0 |
| Name | Holding Percent | Holding Id |
|---|
| Name | Holding Percent | Holding Id |
|---|---|---|
| HUF | 1.18 | 75055304 |
| Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| Nov 02, 2021 | 1 | INTERIM | Nov 04, 2021 | Equity Share |
| Ex-Date | Split Ratio | Record Date |
|---|
| Ex-Date | Purpose | Notes |
|---|---|---|
| May 30, 2024 | Audited Results | - |
| Feb 14, 2024 | Quarterly Results | - |
| Nov 14, 2023 | Quarterly Results | - |
| Aug 14, 2023 | Quarterly Results | - |
| May 30, 2023 | Audited Results | - |
| Mar 06, 2023 | Preferential issue of shares | - |
| Feb 14, 2023 | Quarterly Results | - |
| Nov 14, 2022 | Quarterly Results | - |
| Oct 17, 2022 | Preferential issue of shares | - |
| Aug 14, 2022 | Quarterly Results | - |
| May 30, 2022 | Audited Results & Bonus issue | - |
| Feb 14, 2022 | Quarterly Results | - |
| Oct 25, 2021 | Half Yearly Results & Dividend | - |
| Aug 06, 2021 | Bonus issue & Others | To consider and approve the Migration of the Company from BSE SME Platform to Main Board of BSE Limited. |
| Jun 30, 2021 | Audited Results | - |
| Nov 12, 2020 | Half Yearly Results | - |
| Jul 21, 2020 | Audited & Half Yearly Results | - |
| Jun 30, 2020 | Audited Results | - |
| Nov 14, 2019 | Half Yearly Results | - |
| May 28, 2019 | Audited Results | - |
| Nov 14, 2018 | Quarterly Results | - |
| May 30, 2018 | Audited Results & Dividend | - |
| Nov 21, 2017 | Quarterly Results | (Revised) |
| Ex-Date | Bonus Ratio | Record Date |
|---|---|---|
| Jul 13, 2022 | 1:4 | 2022-07-14 |
| Sep 22, 2021 | 1:1 | 2021-09-23 |
29 Jun 2024
ANG Lifesciences India Ltd - 540694 - Closure of Trading Window
Intimation of Closure of Trading Window
27 Jun 2024
ANG Lifesciences India Ltd - 540694 - Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation, 2015.
We are pleased to informed you that a unit III of Ind-Swift Ltd has now been legitimately registered in the name of ANG Lifesciences India Limited as Unit V. Further details are enclosed herewith disclosure.
13 Jun 2024
ANG Lifesciences India Ltd - 540694 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Reg 30 & 47 of SEBI(LODR) Regulations, 2015, enclosed are the copies of Newspaper advertisements of Audited Financial Results of quarter and year ended at 31.03.2024.
13 Jun 2024
ANG Lifesciences India Ltd - 540694 - Announcement under Regulation 30 (LODR)-Cessation
Resignation of Mr. Pawanjit Singh w.e.f 28.05.2024 due to completion of his tenure.
30 May 2024
ANG Lifesciences India Ltd - 540694 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report for FY 2023-24
30 May 2024
ANG Lifesciences India Ltd - 540694 - Financial Result For Quarter And Year Ended As At 31.03.2024
Financial Result (Standalone & Consolidated) for quarter and year ended as at 31.03.2024
30 May 2024
ANG Lifesciences India Ltd - 540694 - Board Meeting Outcome for Outcome Of Board Meeting
Considered and approved the Audited Standalone and Consolidated Financial Results for the Quarter and Financial Year ended 31st March, 2024. The said Audited Financial Results were reviewed by Audit Committee and thereafter approved by the Board of Directors.
27 May 2024
ANG Lifesciences India Ltd - 540694 - Announcement under Regulation 30 (LODR)-Meeting Updates
In pursuant to Reg. 30 of SEBI LODR, 2015, The Board of Directors of the company appointed Mr. Harvinder Singh as an Additional Director in the capacity of Independent Director w.e.f. 27.05.2024
24 May 2024
ANG Lifesciences India Ltd - 540694 - Board Meeting Intimation for Approval Of Audited Financial Standalone And Consolidated Statements For Quarter And Year Ended 31.03.2024.
ANG Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2024 ,inter alia, to consider and approve 1. The Standalone and Consolidated Audited Financial Results of the Company for the quarter and year ended 31st March, 2024. 2. Any other business that may be necessary with the permission of Chairman.
13 May 2024
ANG Lifesciences India Ltd - 540694 - Announcement under Regulation 30 (LODR)-Meeting Updates
As per regulation 30 (read with Part A of Schedule III) and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Mrs. Saruchi Gupta has been appointed as Chief Financial Officer of the company on the recommendation of Nomination and Remuneration Committee.
